SGLT2 Inhibitors Therapy(University Of Minnesota)

N/A

Report date: 2025/09/19 20:01:00

Base Information

Drug NameSGLT2 Inhibitors Therapy(University Of Minnesota)
Drug Alias NameSGLT2i(University Of Minnesota)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2
Therapy Area/IndicationsIschemic StrokeCardiovascular DiseasesAcute Kidney Injury +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of MedicineUniversidade Federal Do Ceará
Inactive CompaniesUniversity Of Minnesota
Active IndicationsIschemic StrokeCardiovascular DiseasesRejection in heart transplantation
Inactive IndicationsAcute Kidney Injury

Other Information

ATC CodeN/A
Related LinksN/A